| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/04/2006 | CA2585125A1 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents |
| 05/04/2006 | CA2585122A1 M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders |
| 05/04/2006 | CA2585113A1 Tetracyclic indole derivatives as antiviral agents |
| 05/04/2006 | CA2585112A1 Fused pyrimidines and their use as inhibitors of pi3k |
| 05/04/2006 | CA2585089A1 Fused pyrimidines and their use as inhibitors of pi3k |
| 05/04/2006 | CA2585084A1 Tetracyclic indole derivatives as antiviral agents |
| 05/04/2006 | CA2585030A1 New indole or benzimidazole derivatives |
| 05/04/2006 | CA2585014A1 Methylphenidate analogs and methods of use thereof |
| 05/04/2006 | CA2584904A1 Xanthine derivatives with hm74a receptor activity |
| 05/04/2006 | CA2584879A1 Presbyopia treatment by lens alteration |
| 05/04/2006 | CA2584838A1 Novel diazabicyclic aryl derivatives and their medical use |
| 05/04/2006 | CA2584794A1 Tricyclic spacer systems for nonlinear optical devices |
| 05/04/2006 | CA2584775A1 Asymmetric synthesis of dihydrobenzofuran derivatives |
| 05/04/2006 | CA2584752A1 Triazoles useful as inhibitors of protein kinases |
| 05/04/2006 | CA2584728A1 Asymmetric synthesis of substituted dihydrobenzofurans |
| 05/04/2006 | CA2584664A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/04/2006 | CA2584598A1 Heterocyclic indanone potentiators of metabotropic glutamate receptors |
| 05/04/2006 | CA2584547A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 05/04/2006 | CA2584489A1 Kaspp (lrrke) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 05/04/2006 | CA2584481A1 Pharmaceutical compositions based on nk2 antagonists for pediatric use |
| 05/04/2006 | CA2584465A1 Heterocyclic carbonyl compounds and their use as sgk-inhibitors |
| 05/04/2006 | CA2584413A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2584409A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2584318A1 Quinoline derivatives |
| 05/04/2006 | CA2584259A1 Imidazo-benzodiazepine derivatives |
| 05/04/2006 | CA2584241A1 Cgrp receptor antagonists |
| 05/04/2006 | CA2584167A1 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 05/04/2006 | CA2583756A1 Pharmaceutical composition comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 05/04/2006 | CA2583681A1 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/04/2006 | CA2583642A1 Transdermal delivery systems |
| 05/04/2006 | CA2583550A1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor |
| 05/04/2006 | CA2583446A1 Method of using adapalene in acne maintenance therapy |
| 05/04/2006 | CA2582434A1 Purine derivatives for use as adenosin a-2a receptor agonists |
| 05/04/2006 | CA2582247A1 3-arylamino pyridine derivatives |
| 05/04/2006 | CA2582079A1 Indole compounds useful as serotonin selective agents |
| 05/04/2006 | CA2581981A1 Mif-inhibitors |
| 05/04/2006 | CA2581807A1 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 05/04/2006 | CA2581298A1 Combination of dpp-iv inhibitor, ppar antidiabetic and metformin |
| 05/04/2006 | CA2581223A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 05/04/2006 | CA2581207A1 The treatment of inflammatory bowel disease |
| 05/04/2006 | CA2580919A1 Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof |
| 05/04/2006 | CA2580690A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/04/2006 | CA2580475A1 Pyrrolo [1,2-d][1,2-4]triazine as inhibitors of c-jun n terminal kinases (jnk) and p-38 kinases |
| 05/04/2006 | CA2580119A1 Amorphous object of cinnamide compound |
| 05/04/2006 | CA2577862A1 Pharmaceutical composition comprising diclofenac |
| 05/04/2006 | CA2577588A1 Hiv inhibiting bicyclic pyrimidine derivatives |
| 05/03/2006 | EP1652931A2 Recombinant adenoviruses, preparation and uses thereof for the treatment and/or prevention ofs cancers |
| 05/03/2006 | EP1652928A1 Plant producing hyaluronic acid |
| 05/03/2006 | EP1652923A1 Gene overexpressed in cancer |
| 05/03/2006 | EP1652913A1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 05/03/2006 | EP1652854A1 Indolopyrrolocabazole derivative and antitumor agent |
| 05/03/2006 | EP1652849A1 Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents |
| 05/03/2006 | EP1652848A1 Process for producing imide compound |
| 05/03/2006 | EP1652847A1 Quinoline and quinazoline derivatives for the treatment of tumors |
| 05/03/2006 | EP1652843A1 Amide derivatives |
| 05/03/2006 | EP1652839A2 Drug efflux pump inhibitor |
| 05/03/2006 | EP1652539A1 Method of manufacturing a stent comprising an anti-angiogenic composition |
| 05/03/2006 | EP1652533A1 HEART-SLOWING DRUG CONTAINING SHORT-ACTING &bgr; BLOCKER AS THE ACTIVE INGREDIENT |
| 05/03/2006 | EP1652532A1 Medicinal composition |
| 05/03/2006 | EP1652527A1 Accelerator for mineral absorption and use thereof |
| 05/03/2006 | EP1652526A2 Use of (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder |
| 05/03/2006 | EP1652525A1 Anti-coronavirus drug |
| 05/03/2006 | EP1652524A1 Dry syrup containing loratadine |
| 05/03/2006 | EP1652523A1 Transdermal absorption preparation |
| 05/03/2006 | EP1652522A1 Sustained release tablet for oral use |
| 05/03/2006 | EP1652521A1 Pharmaceutical composition of sildenafil and a large conductance Ca(2+) activated K+ channels activator |
| 05/03/2006 | EP1652520A2 Formulations useful in the treatment of male and female impotence |
| 05/03/2006 | EP1652519A1 Seleniferous composition for producing antioxidase in vivo |
| 05/03/2006 | EP1652518A1 Pharmaceutical composition for sublingual administration |
| 05/03/2006 | EP1652516A2 Osmotic controlled delivery of active agents |
| 05/03/2006 | EP1652514A1 At-use dispersed preparation |
| 05/03/2006 | EP1652512A1 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation |
| 05/03/2006 | EP1652508A1 Adhesive patch |
| 05/03/2006 | EP1651963A2 Monocarboxylate transporters expressed in cancer cells |
| 05/03/2006 | EP1651762A2 Small interfering rna specific to sub-units $g(a), $g(a)' and $g(b) of the kinase protein ck2, and the applications of the same |
| 05/03/2006 | EP1651677A2 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures |
| 05/03/2006 | EP1651676A2 Therapy-enhancing glucan |
| 05/03/2006 | EP1651661A1 Process for the preparation of finasteride form i |
| 05/03/2006 | EP1651658A1 Novel compounds having inhibitory activity against sodium-dependant transporter |
| 05/03/2006 | EP1651656A1 Process for controlling crystal structure of risedronate |
| 05/03/2006 | EP1651648A2 Compounds and compositions as protein kinase inhibitors |
| 05/03/2006 | EP1651647A1 Nicotinamide derivatives useful as pdea4 inhibitors |
| 05/03/2006 | EP1651646A1 A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i |
| 05/03/2006 | EP1651643A2 Bicyclic compounds and compositions as pdf inhibitors |
| 05/03/2006 | EP1651642A1 Pna monomer and precursor |
| 05/03/2006 | EP1651641A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651640A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651639A1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 05/03/2006 | EP1651638A1 Pyridyl piperazinyl ureas |
| 05/03/2006 | EP1651636A1 Substituted heterocyclic diarylamine analogues |
| 05/03/2006 | EP1651635A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651634A1 Imidazol derivatives of piperidine as histamine antagonists |
| 05/03/2006 | EP1651629A1 Substituted benzothiophene compounds and uses thereof |
| 05/03/2006 | EP1651628A2 Antibiotic compound |
| 05/03/2006 | EP1651623A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/03/2006 | EP1651620A2 Piperazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651616A2 Pyridazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651611A2 Benzimidazole c-2 heterocycles as kinase inhibitors |
| 05/03/2006 | EP1651609A1 Nicotinamide derivatives useful as pde4 inhibitors |